Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $5.02 billion. The enterprise value is $5.51 billion.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 123.42 million shares outstanding. The number of shares has increased by 9.61% in one year.
| Current Share Class | 123.42M |
| Shares Outstanding | 123.42M |
| Shares Change (YoY) | +9.61% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 4.31% |
| Owned by Institutions (%) | 91.46% |
| Float | 111.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.75 |
| Forward PS | 5.71 |
| PB Ratio | -35.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.68
| Current Ratio | 4.68 |
| Quick Ratio | 4.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -171.87 |
Financial Efficiency
Return on equity (ROE) is -4,584.47% and return on invested capital (ROIC) is -20.47%.
| Return on Equity (ROE) | -4,584.47% |
| Return on Assets (ROA) | -16.95% |
| Return on Invested Capital (ROIC) | -20.47% |
| Return on Capital Employed (ROCE) | -35.21% |
| Revenue Per Employee | $365,668 |
| Profits Per Employee | -$215,919 |
| Employee Count | 2,021 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 4.36 |
Taxes
In the past 12 months, Guardant Health has paid $1.28 million in taxes.
| Income Tax | 1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +118.03% in the last 52 weeks. The beta is 1.50, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +118.03% |
| 50-Day Moving Average | 42.26 |
| 200-Day Moving Average | 31.80 |
| Relative Strength Index (RSI) | 46.62 |
| Average Volume (20 Days) | 2,656,601 |
Short Selling Information
The latest short interest is 7.84 million, so 6.35% of the outstanding shares have been sold short.
| Short Interest | 7.84M |
| Short Previous Month | 5.77M |
| Short % of Shares Out | 6.35% |
| Short % of Float | 7.02% |
| Short Ratio (days to cover) | 3.28 |
Income Statement
In the last 12 months, Guardant Health had revenue of $739.02 million and -$436.37 million in losses. Loss per share was -$3.56.
| Revenue | 739.02M |
| Gross Profit | 449.22M |
| Operating Income | -443.59M |
| Pretax Income | -490.27M |
| Net Income | -436.37M |
| EBITDA | -401.21M |
| EBIT | -443.59M |
| Loss Per Share | -$3.56 |
Full Income StatementBalance Sheet
The company has $839.98 million in cash and $1.34 billion in debt, giving a net cash position of -$496.07 million or -$4.02 per share.
| Cash & Cash Equivalents | 839.98M |
| Total Debt | 1.34B |
| Net Cash | -496.07M |
| Net Cash Per Share | -$4.02 |
| Equity (Book Value) | -139.65M |
| Book Value Per Share | -1.13 |
| Working Capital | 829.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$239.86 million and capital expenditures -$35.09 million, giving a free cash flow of -$274.94 million.
| Operating Cash Flow | -239.86M |
| Capital Expenditures | -35.09M |
| Free Cash Flow | -274.94M |
| FCF Per Share | -$2.23 |
Full Cash Flow StatementMargins
Gross margin is 60.79%, with operating and profit margins of -60.02% and -59.05%.
| Gross Margin | 60.79% |
| Operating Margin | -60.02% |
| Pretax Margin | -58.87% |
| Profit Margin | -59.05% |
| EBITDA Margin | -54.29% |
| EBIT Margin | -60.02% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.61% |
| Shareholder Yield | -9.61% |
| Earnings Yield | -8.70% |
| FCF Yield | -5.48% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $48.40, which is 19.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $48.40 |
| Price Target Difference | 19.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 19.69% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of -1.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.1 |
| Piotroski F-Score | 3 |